Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Marinol, Cannibinol
Generic Name: Dronabinol
Dronabinol is a synthetic form of the active ingredient in marijuana, THC. It is an anti-emetic and appetite stimulant used for chemotherapy-associated nausea and vomiting refractory to other antiemetic(s); and for AIDS-related anorexia.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Pain | 22 | 3 |
|
||||
| Stiffness/Spasticity | 16 | 5 |
|
|
|
|
|
| Decreased appetite | 12 | 1 |
|
||||
| Other | 11 | 2 |
|
|
|||
| Nausea | 11 | 3 |
|
|
|
||
| Aching burning throbbing body pain | 4 | 0 |
See all 74 patients currently taking Dronabinol
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Dronabinol
| Walking problems | 1 | |
|---|---|---|
| Brain fog | 1 | |
| Weight gain | 1 | |
| Lack of motivation | 1 | |
| Grogginess | 1 | |
| Mood elevated or improved | 1 | |
| See all 8 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Dronabinol. See all 21 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 5 | ||
| Expense | 4 | ||
| Other | 3 | ||
| Change in health plan coverage | 2 | ||
| Course of treatment ended | 1 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Dronabinol
Always |
6 | 38% |
|
|---|---|---|---|
Usually |
4 | 25% |
|
Sometimes |
5 | 31% |
|
Never |
1 | 6% |
|
Burden
Difficulty being on treatment
Burden of Dronabinol
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
2 | 13% |
|
A little |
3 | 19% |
|
Not at all |
11 | 69% |
|
Cost
Paid out of pocket
Cost of Dronabinol
$200+ |
1 | 10% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
1 | 10% |
|
$25-49 |
1 | 10% |
|
< $25 |
6 | 60% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 25, 2012.